Tag:
Gentium
Latest Headlines
Latest Headlines
Gentium tanks after it yanks drug app on FDA data concerns
Shares of Italy's Gentium tanked overnight after the drug developer announced that regulators had raised some serious questions regarding the quality of its data for the vascular drug defibrotide.
Gentium names CEO, closes NY office
Following it's license agreement with Sigma-Tau, Gentium said it will be closing its New York office and consolidating corporate activities and the executive management team within its headquarters
Gentium shares sink on Phase III vein drug failure
Italy's Gentium saw its shares sag on the news that its experimental therapy to treat the blockage of small veins in the liver failed the primary and secondary endpoints of a late-stage trial. The
